Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.535 USD | -0.23% | -0.15% | -26.75% |
May. 20 | HC Wainwright Starts Coverage on Prime Medicine With Buy Rating, $10 Price Target | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.75% | 757M | |
+15.11% | 121B | |
+12.84% | 107B | |
-5.22% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-42.28% | 16.33B | |
-15.21% | 15.31B | |
+2.58% | 14.08B | |
+25.22% | 11.74B |
- Stock Market
- Equities
- PRME Stock
- News Prime Medicine, Inc.
- Morgan Stanley Cuts Price Target on Prime Medicine to $12 From $18, Keeps Equalweight Rating